Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1998 Jul;35(7):579–589. doi: 10.1136/jmg.35.7.579

The fragile X syndrome.

B B de Vries 1, D J Halley 1, B A Oostra 1, M F Niermeijer 1
PMCID: PMC1051369  PMID: 9678703

Abstract

The fragile X syndrome is characterised by mental retardation, behavioural features, and physical features, such as a long face with large protruding ears and macro-orchidism. In 1991, after identification of the fragile X mental retardation (FMR1) gene, the cytogenetic marker (a fragile site at Xq27.3) became replaced by molecular diagnosis. The fragile X syndrome was one of the first examples of a "novel" class of disorders caused by a trinucleotide repeat expansion. In the normal population, the CGG repeat varies from six to 54 units. Affected subjects have expanded CGG repeats (>200) in the first exon of the FMR1 gene (the full mutation). Phenotypically normal carriers of the fragile X syndrome have a repeat in the 43 to 200 range (the premutation). The cloning of the FMR1 gene led to the characterisation of its protein product FMRP, encouraged further clinical studies, and opened up the possibility of more accurate family studies and fragile X screening programmes.

Full text

PDF
579

Images in this article

580Image
on p.580
581Image
on p.581
582Image
on p.582
583Image
on p.583

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abitbol M., Menini C., Delezoide A. L., Rhyner T., Vekemans M., Mallet J. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet. 1993 Jun;4(2):147–153. doi: 10.1038/ng0693-147. [DOI] [PubMed] [Google Scholar]
  2. Abrams M. T., Reiss A. L., Freund L. S., Baumgardner T. L., Chase G. A., Denckla M. B. Molecular-neurobehavioral associations in females with the fragile X full mutation. Am J Med Genet. 1994 Jul 15;51(4):317–327. doi: 10.1002/ajmg.1320510407. [DOI] [PubMed] [Google Scholar]
  3. Albright S. G., Lachiewicz A. M., Tarleton J. C., Rao K. W., Schwartz C. E., Richie R., Tennison M. B., Aylsworth A. S. Fragile X phenotype in a patient with a large de novo deletion in Xq27-q28. Am J Med Genet. 1994 Jul 15;51(4):294–297. doi: 10.1002/ajmg.1320510403. [DOI] [PubMed] [Google Scholar]
  4. Arvio M., Peippo M., Simola K. O. Applicability of a checklist for clinical screening of the fragile X syndrome. Clin Genet. 1997 Oct;52(4):211–215. doi: 10.1111/j.1399-0004.1997.tb02549.x. [DOI] [PubMed] [Google Scholar]
  5. Ashley C. T., Jr, Wilkinson K. D., Reines D., Warren S. T. FMR1 protein: conserved RNP family domains and selective RNA binding. Science. 1993 Oct 22;262(5133):563–566. doi: 10.1126/science.7692601. [DOI] [PubMed] [Google Scholar]
  6. Ashley C. T., Sutcliffe J. S., Kunst C. B., Leiner H. A., Eichler E. E., Nelson D. L., Warren S. T. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nat Genet. 1993 Jul;4(3):244–251. doi: 10.1038/ng0793-244. [DOI] [PubMed] [Google Scholar]
  7. Beemer F. A., Veenema H., de Pater J. M. Cerebral gigantism (Sotos syndrome) in two patients with fra(X) chromosomes. Am J Med Genet. 1986 Jan-Feb;23(1-2):221–226. doi: 10.1002/ajmg.1320230117. [DOI] [PubMed] [Google Scholar]
  8. Bonthron D., Strain L. Population screening for fragile-X syndrome. Lancet. 1993 Mar 20;341(8847):769–770. doi: 10.1016/0140-6736(93)90552-r. [DOI] [PubMed] [Google Scholar]
  9. Boucher C. A., King S. K., Carey N., Krahe R., Winchester C. L., Rahman S., Creavin T., Meghji P., Bailey M. E., Chartier F. L. A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum Mol Genet. 1995 Oct;4(10):1919–1925. doi: 10.1093/hmg/4.10.1919. [DOI] [PubMed] [Google Scholar]
  10. Brown W. T., Houck G. E., Jr, Ding X., Zhong N., Nolin S., Glicksman A., Dobkin C., Jenkins E. C. Reverse mutations in the fragile X syndrome. Am J Med Genet. 1996 Aug 9;64(2):287–292. doi: 10.1002/(SICI)1096-8628(19960809)64:2<287::AID-AJMG11>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  11. Bundey S., Norman E. Population screening for fragile-X syndrome. Lancet. 1993 Mar 20;341(8847):770–770. [PubMed] [Google Scholar]
  12. Butler M. G., Brunschwig A., Miller L. K., Hagerman R. J. Standards for selected anthropometric measurements in males with the fragile X syndrome. Pediatrics. 1992 Jun;89(6 Pt 1):1059–1062. [PMC free article] [PubMed] [Google Scholar]
  13. Butler M. G., Mangrum T., Gupta R., Singh D. N. A 15-item checklist for screening mentally retarded males for the fragile X syndrome. Clin Genet. 1991 May;39(5):347–354. doi: 10.1111/j.1399-0004.1991.tb03041.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cantú J. M., Scaglia H. E., Medina M., González-Diddi M., Morato T., Moreno M. E., Pérez-Palacios G. Inherited congenital normofunctional testicular hyperplasia and mental deficiency. Hum Genet. 1976 Jul 7;33(1):23–33. doi: 10.1007/BF00447283. [DOI] [PubMed] [Google Scholar]
  15. Cohen I. L., Nolin S. L., Sudhalter V., Ding X. H., Dobkin C. S., Brown W. T. Mosaicism for the FMR1 gene influences adaptive skills development in fragile X-affected males. Am J Med Genet. 1996 Aug 9;64(2):365–369. doi: 10.1002/(SICI)1096-8628(19960809)64:2<365::AID-AJMG26>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  16. Cohen I. L., Sudhalter V., Pfadt A., Jenkins E. C., Brown W. T., Vietze P. M. Why are autism and the fragile-X syndrome associated? Conceptual and methodological issues. Am J Hum Genet. 1991 Feb;48(2):195–202. [PMC free article] [PubMed] [Google Scholar]
  17. Comery T. A., Harris J. B., Willems P. J., Oostra B. A., Irwin S. A., Weiler I. J., Greenough W. T. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A. 1997 May 13;94(10):5401–5404. doi: 10.1073/pnas.94.10.5401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Corbin F., Bouillon M., Fortin A., Morin S., Rousseau F., Khandjian E. W. The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes. Hum Mol Genet. 1997 Sep;6(9):1465–1472. doi: 10.1093/hmg/6.9.1465. [DOI] [PubMed] [Google Scholar]
  19. Craft N. Study supports screening for the fragile X syndrome. BMJ. 1995 Jan 21;310(6973):148–148. doi: 10.1136/bmj.310.6973.148a. [DOI] [PubMed] [Google Scholar]
  20. Curfs L. M., Wiegers A. M., Fryns J. P. Intelligence and the fra(X) syndrome: a review. Genet Couns. 1991;2(1):55–62. [PubMed] [Google Scholar]
  21. De Boulle K., Verkerk A. J., Reyniers E., Vits L., Hendrickx J., Van Roy B., Van den Bos F., de Graaff E., Oostra B. A., Willems P. J. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet. 1993 Jan;3(1):31–35. doi: 10.1038/ng0193-31. [DOI] [PubMed] [Google Scholar]
  22. De Vries B. B., Niermeijer M. F. The Prader-Willi-like phenotype in fragile X patients: a designation facilitating clinical (and molecular) differential diagnosis. J Med Genet. 1994 Oct;31(10):820–820. doi: 10.1136/jmg.31.10.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Devys D., Biancalana V., Rousseau F., Boué J., Mandel J. L., Oberlé I. Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development. 1992 Apr 15-May 1Am J Med Genet. 43(1-2):208–216. doi: 10.1002/ajmg.1320430134. [DOI] [PubMed] [Google Scholar]
  24. Devys D., Lutz Y., Rouyer N., Bellocq J. P., Mandel J. L. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet. 1993 Aug;4(4):335–340. doi: 10.1038/ng0893-335. [DOI] [PubMed] [Google Scholar]
  25. Drugge U., Holmgren G., Blomquist H. K., Dahl N., Gustavson K. H., Malmgren H. Study of individuals possibly affected with the fragile X syndrome in a large Swedish family in the 18th to 20th centuries. 1992 Apr 15-May 1Am J Med Genet. 43(1-2):353–354. doi: 10.1002/ajmg.1320430154. [DOI] [PubMed] [Google Scholar]
  26. Eberhart D. E., Malter H. E., Feng Y., Warren S. T. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet. 1996 Aug;5(8):1083–1091. doi: 10.1093/hmg/5.8.1083. [DOI] [PubMed] [Google Scholar]
  27. Eichler E. E., Holden J. J., Popovich B. W., Reiss A. L., Snow K., Thibodeau S. N., Richards C. S., Ward P. A., Nelson D. L. Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet. 1994 Sep;8(1):88–94. doi: 10.1038/ng0994-88. [DOI] [PubMed] [Google Scholar]
  28. Eichler E. E., Richards S., Gibbs R. A., Nelson D. L. Fine structure of the human FMR1 gene. Hum Mol Genet. 1993 Aug;2(8):1147–1153. doi: 10.1093/hmg/2.8.1147. [DOI] [PubMed] [Google Scholar]
  29. Feng Y., Lakkis L., Devys D., Warren S. T. Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am J Hum Genet. 1995 Jan;56(1):106–113. [PMC free article] [PubMed] [Google Scholar]
  30. Fisch G. S., Arinami T., Froster-Iskenius U., Fryns J. P., Curfs L. M., Borghgraef M., Howard-Peebles P. N., Schwartz C. E., Simensen R. J., Shapiro L. R. Relationship between age and IQ among fragile X males: a multicenter study. Am J Med Genet. 1991 Feb-Mar;38(2-3):481–487. doi: 10.1002/ajmg.1320380268. [DOI] [PubMed] [Google Scholar]
  31. Fisch G. S. What is associated with the fragile X syndrome? Am J Med Genet. 1993 Jul 15;48(2):112–121. doi: 10.1002/ajmg.1320480210. [DOI] [PubMed] [Google Scholar]
  32. Fryns J. P., Haspeslagh M., Dereymaeker A. M., Volcke P., Van den Berghe H. A peculiar subphenotype in the fra(X) syndrome: extreme obesity-short stature-stubby hands and feet-diffuse hyperpigmentation. Further evidence of disturbed hypothalamic function in the fra(X) syndrome? Clin Genet. 1987 Dec;32(6):388–392. doi: 10.1111/j.1399-0004.1987.tb03155.x. [DOI] [PubMed] [Google Scholar]
  33. Fryns J. P., Van den Berghe H. The concurrence of Klinefelter syndrome and fragile X syndrome. Am J Med Genet. 1988 May-Jun;30(1-2):109–113. doi: 10.1002/ajmg.1320300109. [DOI] [PubMed] [Google Scholar]
  34. Fu Y. H., Kuhl D. P., Pizzuti A., Pieretti M., Sutcliffe J. S., Richards S., Verkerk A. J., Holden J. J., Fenwick R. G., Jr, Warren S. T. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991 Dec 20;67(6):1047–1058. doi: 10.1016/0092-8674(91)90283-5. [DOI] [PubMed] [Google Scholar]
  35. Gedeon A. K., Baker E., Robinson H., Partington M. W., Gross B., Manca A., Korn B., Poustka A., Yu S., Sutherland G. R. Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat Genet. 1992 Aug;1(5):341–344. doi: 10.1038/ng0892-341. [DOI] [PubMed] [Google Scholar]
  36. Giangreco C. A., Steele M. W., Aston C. E., Cummins J. H., Wenger S. L. A simplified six-item checklist for screening for fragile X syndrome in the pediatric population. J Pediatr. 1996 Oct;129(4):611–614. doi: 10.1016/s0022-3476(96)70130-0. [DOI] [PubMed] [Google Scholar]
  37. Gibson T. J., Rice P. M., Thompson J. D., Heringa J. KH domains within the FMR1 sequence suggest that fragile X syndrome stems from a defect in RNA metabolism. Trends Biochem Sci. 1993 Sep;18(9):331–333. doi: 10.1016/0968-0004(93)90068-x. [DOI] [PubMed] [Google Scholar]
  38. Goldson E., Hagerman R. J. Fragile X syndrome and failure to thrive. Am J Dis Child. 1993 Jun;147(6):605–607. doi: 10.1001/archpedi.1993.02160300011002. [DOI] [PubMed] [Google Scholar]
  39. Grønskov K., Hjalgrim H., Bjerager M. O., Brøndum-Nielsen K. Deletion of all CGG repeats plus flanking sequences in FMR1 does not abolish gene expression. Am J Hum Genet. 1997 Oct;61(4):961–967. doi: 10.1086/514872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Gu Y., Lugenbeel K. A., Vockley J. G., Grody W. W., Nelson D. L. A de novo deletion in FMR1 in a patient with developmental delay. Hum Mol Genet. 1994 Sep;3(9):1705–1706. doi: 10.1093/hmg/3.9.1705. [DOI] [PubMed] [Google Scholar]
  41. Gustavson K. H., Blomquist H. K., Holmgren G. Prevalence of the fragile-X syndrome in mentally retarded boys in a Swedish county. Am J Med Genet. 1986 Jan-Feb;23(1-2):581–587. doi: 10.1002/ajmg.1320230152. [DOI] [PubMed] [Google Scholar]
  42. Hagerman R. J., Altshul-Stark D., McBogg P. Recurrent otitis media in the fragile X syndrome. Am J Dis Child. 1987 Feb;141(2):184–187. doi: 10.1001/archpedi.1987.04460020074031. [DOI] [PubMed] [Google Scholar]
  43. Hagerman R. J., Amiri K., Cronister A. Fragile X checklist. Am J Med Genet. 1991 Feb-Mar;38(2-3):283–287. doi: 10.1002/ajmg.1320380223. [DOI] [PubMed] [Google Scholar]
  44. Hagerman R. J., Hull C. E., Safanda J. F., Carpenter I., Staley L. W., O'Connor R. A., Seydel C., Mazzocco M. M., Snow K., Thibodeau S. N. High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet. 1994 Jul 15;51(4):298–308. doi: 10.1002/ajmg.1320510404. [DOI] [PubMed] [Google Scholar]
  45. Hagerman R. J., Wilson P., Staley L. W., Lang K. A., Fan T., Uhlhorn C., Jewell-Smart S., Hull C., Drisko J., Flom K. Evaluation of school children at high risk for fragile X syndrome utilizing buccal cell FMR-1 testing. Am J Med Genet. 1994 Jul 15;51(4):474–481. doi: 10.1002/ajmg.1320510436. [DOI] [PubMed] [Google Scholar]
  46. Halley D., Van Den Ouweland A., Deelen W., Verma I., Oostra B. Strategy for reliable prenatal detection of normal male carriers of the fragile X syndrome. Am J Med Genet. 1994 Jul 15;51(4):471–473. doi: 10.1002/ajmg.1320510435. [DOI] [PubMed] [Google Scholar]
  47. Hammond L. S., Macias M. M., Tarleton J. C., Shashidhar Pai G. Fragile X syndrome and deletions in FMR1: new case and review of the literature. Am J Med Genet. 1997 Nov 12;72(4):430–434. [PubMed] [Google Scholar]
  48. Hansen R. S., Gartler S. M., Scott C. R., Chen S. H., Laird C. D. Methylation analysis of CGG sites in the CpG island of the human FMR1 gene. Hum Mol Genet. 1992 Nov;1(8):571–578. doi: 10.1093/hmg/1.8.571. [DOI] [PubMed] [Google Scholar]
  49. Heitz D., Devys D., Imbert G., Kretz C., Mandel J. L. Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation. J Med Genet. 1992 Nov;29(11):794–801. doi: 10.1136/jmg.29.11.794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Hinds H. L., Ashley C. T., Sutcliffe J. S., Nelson D. L., Warren S. T., Housman D. E., Schalling M. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet. 1993 Jan;3(1):36–43. doi: 10.1038/ng0193-36. [DOI] [PubMed] [Google Scholar]
  51. Hinton V. J., Brown W. T., Wisniewski K., Rudelli R. D. Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet. 1991 Dec 1;41(3):289–294. doi: 10.1002/ajmg.1320410306. [DOI] [PubMed] [Google Scholar]
  52. Hirst M. C., Barnicoat A., Flynn G., Wang Q., Daker M., Buckle V. J., Davies K. E., Bobrow M. The identification of a third fragile site, FRAXF, in Xq27--q28 distal to both FRAXA and FRAXE. Hum Mol Genet. 1993 Feb;2(2):197–200. doi: 10.1093/hmg/2.2.197. [DOI] [PubMed] [Google Scholar]
  53. Hirst M. C. FMR1 triplet arrays: paying the price for perfection. J Med Genet. 1995 Oct;32(10):761–763. doi: 10.1136/jmg.32.10.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Hirst M. C., Grewal P. K., Davies K. E. Precursor arrays for triplet repeat expansion at the fragile X locus. Hum Mol Genet. 1994 Sep;3(9):1553–1560. doi: 10.1093/hmg/3.9.1553. [DOI] [PubMed] [Google Scholar]
  55. Hirst M., Grewal P., Flannery A., Slatter R., Maher E., Barton D., Fryns J. P., Davies K. Two new cases of FMR1 deletion associated with mental impairment. Am J Hum Genet. 1995 Jan;56(1):67–74. [PMC free article] [PubMed] [Google Scholar]
  56. Howard-Peebles P. N., Maddalena A., Black S. H., Schulman J. D. Population screening for fragile-X syndrome. Lancet. 1993 Mar 20;341(8847):770–770. [PubMed] [Google Scholar]
  57. Jacobs P. A., Bullman H., Macpherson J., Youings S., Rooney V., Watson A., Dennis N. R. Population studies of the fragile X: a molecular approach. J Med Genet. 1993 Jun;30(6):454–459. doi: 10.1136/jmg.30.6.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Johannisson R., Rehder H., Wendt V., Schwinger E. Spermatogenesis in two patients with the fragile X syndrome. I. Histology: light and electron microscopy. Hum Genet. 1987 Jun;76(2):141–147. doi: 10.1007/BF00284911. [DOI] [PubMed] [Google Scholar]
  59. Kenneson A., Cramer D. W., Warren S. T. Fragile X premutations are not a major cause of early menopause. Am J Hum Genet. 1997 Dec;61(6):1362–1369. doi: 10.1086/301647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Khandjian E. W., Corbin F., Woerly S., Rousseau F. The fragile X mental retardation protein is associated with ribosomes. Nat Genet. 1996 Jan;12(1):91–93. doi: 10.1038/ng0196-91. [DOI] [PubMed] [Google Scholar]
  61. Kooy R. F., D'Hooge R., Reyniers E., Bakker C. E., Nagels G., De Boulle K., Storm K., Clincke G., De Deyn P. P., Oostra B. A. Transgenic mouse model for the fragile X syndrome. Am J Med Genet. 1996 Aug 9;64(2):241–245. doi: 10.1002/(SICI)1096-8628(19960809)64:2<241::AID-AJMG1>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  62. Kunst C. B., Warren S. T. Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles. Cell. 1994 Jun 17;77(6):853–861. doi: 10.1016/0092-8674(94)90134-1. [DOI] [PubMed] [Google Scholar]
  63. Kupke K. G., Soreng A. L., Müller U. Origin of the supernumerary X chromosome in a patient with fragile X and Klinefelter syndrome. Am J Med Genet. 1991 Feb-Mar;38(2-3):440–444. doi: 10.1002/ajmg.1320380260. [DOI] [PubMed] [Google Scholar]
  64. Kähkönen M., Alitalo T., Airaksinen E., Matilainen R., Launiala K., Autio S., Leisti J. Prevalence of the fragile X syndrome in four birth cohorts of children of school age. Hum Genet. 1987 Sep;77(1):85–87. doi: 10.1007/BF00284720. [DOI] [PubMed] [Google Scholar]
  65. Lachiewicz A. M., Gullion C. M., Spiridigliozzi G. A., Aylsworth A. S. Declining IQs of young males with the fragile X syndrome. Am J Ment Retard. 1987 Nov;92(3):272–278. [PubMed] [Google Scholar]
  66. Lachiewicz A. M., Hoegerman S. F., Holmgren G., Holmberg E., Arinbjarnarson K. Association of the Robin sequence with the fragile X syndrome. Am J Med Genet. 1991 Dec 1;41(3):275–278. doi: 10.1002/ajmg.1320410302. [DOI] [PubMed] [Google Scholar]
  67. Laing S., Partington M., Robinson H., Turner G. Clinical screening score for the fragile X (Martin-Bell) syndrome. Am J Med Genet. 1991 Feb-Mar;38(2-3):256–259. doi: 10.1002/ajmg.1320380219. [DOI] [PubMed] [Google Scholar]
  68. Laxova R. Fragile X screening: what is the real issue? Am J Med Genet. 1995 Jul 3;57(3):508–509. doi: 10.1002/ajmg.1320570335. [DOI] [PubMed] [Google Scholar]
  69. Loehr J. P., Synhorst D. P., Wolfe R. R., Hagerman R. J. Aortic root dilatation and mitral valve prolapse in the fragile X syndrome. Am J Med Genet. 1986 Jan-Feb;23(1-2):189–194. doi: 10.1002/ajmg.1320230113. [DOI] [PubMed] [Google Scholar]
  70. Loesch D. Z., Hay D. A., Sheffield L. J. Fragile X family with unusual digital and facial abnormalities, cleft lip and palate, and epilepsy. Am J Med Genet. 1992 Nov 15;44(5):543–550. doi: 10.1002/ajmg.1320440502. [DOI] [PubMed] [Google Scholar]
  71. Loesch D. Z., Huggins R., Hay D. A., Gedeon A. K., Mulley J. C., Sutherland G. R. Genotype-phenotype relationships in fragile X syndrome: a family study. Am J Hum Genet. 1993 Nov;53(5):1064–1073. [PMC free article] [PubMed] [Google Scholar]
  72. Loesch D. Z., Lafranchi M., Scott D. Anthropometry in Martin-Bell syndrome. Am J Med Genet. 1988 May-Jun;30(1-2):149–164. doi: 10.1002/ajmg.1320300113. [DOI] [PubMed] [Google Scholar]
  73. Lugenbeel K. A., Peier A. M., Carson N. L., Chudley A. E., Nelson D. L. Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome. Nat Genet. 1995 Aug;10(4):483–485. doi: 10.1038/ng0895-483. [DOI] [PubMed] [Google Scholar]
  74. Macpherson J. N., Curtis G., Crolla J. A., Dennis N., Migeon B., Grewal P. K., Hirst M. C., Davies K. E., Jacobs P. A. Unusual (CGG)n expansion and recombination in a family with fragile X and DiGeorge syndrome. J Med Genet. 1995 Mar;32(3):236–239. doi: 10.1136/jmg.32.3.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Maddalena A., Hicks B. D., Spence W. C., Levinson G., Howard-Peebles P. N. Prenatal diagnosis in known fragile X carriers. Am J Med Genet. 1994 Jul 15;51(4):490–496. doi: 10.1002/ajmg.1320510439. [DOI] [PubMed] [Google Scholar]
  76. Malter H. E., Iber J. C., Willemsen R., de Graaff E., Tarleton J. C., Leisti J., Warren S. T., Oostra B. A. Characterization of the full fragile X syndrome mutation in fetal gametes. Nat Genet. 1997 Feb;15(2):165–169. doi: 10.1038/ng0297-165. [DOI] [PubMed] [Google Scholar]
  77. Mannermaa A., Pulkkinen L., Kajanoja E., Ryynänen M., Saarikoski S. Deletion in the FMR1 gene in a fragile-X male. Am J Med Genet. 1996 Aug 9;64(2):293–295. doi: 10.1002/(SICI)1096-8628(19960809)64:2<293::AID-AJMG12>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  78. Martin J. P., Bell J. A PEDIGREE OF MENTAL DEFECT SHOWING SEX-LINKAGE. J Neurol Psychiatry. 1943 Jul;6(3-4):154–157. doi: 10.1136/jnnp.6.3-4.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. McConkie-Rosell A., Lachiewicz A. M., Spiridigliozzi G. A., Tarleton J., Schoenwald S., Phelan M. C., Goonewardena P., Ding X., Brown W. T. Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome. Am J Hum Genet. 1993 Oct;53(4):800–809. [PMC free article] [PubMed] [Google Scholar]
  80. Meadows K. L., Pettay D., Newman J., Hersey J., Ashley A. E., Sherman S. L. Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population. Am J Med Genet. 1996 Aug 9;64(2):428–433. doi: 10.1002/(SICI)1096-8628(19960809)64:2<428::AID-AJMG39>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  81. Meijer H., de Graaff E., Merckx D. M., Jongbloed R. J., de Die-Smulders C. E., Engelen J. J., Fryns J. P., Curfs P. M., Oostra B. A. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome. Hum Mol Genet. 1994 Apr;3(4):615–620. doi: 10.1093/hmg/3.4.615. [DOI] [PubMed] [Google Scholar]
  82. Merenstein S. A., Sobesky W. E., Taylor A. K., Riddle J. E., Tran H. X., Hagerman R. J. Molecular-clinical correlations in males with an expanded FMR1 mutation. Am J Med Genet. 1996 Aug 9;64(2):388–394. doi: 10.1002/(SICI)1096-8628(19960809)64:2<388::AID-AJMG31>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  83. Moutou C., Vincent M. C., Biancalana V., Mandel J. L. Transition from premutation to full mutation in fragile X syndrome is likely to be prezygotic. Hum Mol Genet. 1997 Jul;6(7):971–979. doi: 10.1093/hmg/6.7.971. [DOI] [PubMed] [Google Scholar]
  84. Murray A., Youings S., Dennis N., Latsky L., Linehan P., McKechnie N., Macpherson J., Pound M., Jacobs P. Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers. Hum Mol Genet. 1996 Jun;5(6):727–735. doi: 10.1093/hmg/5.6.727. [DOI] [PubMed] [Google Scholar]
  85. Murray J., Cuckle H., Taylor G., Hewison J. Screening for fragile X syndrome: information needs for health planners. J Med Screen. 1997;4(2):60–94. doi: 10.1177/096914139700400204. [DOI] [PubMed] [Google Scholar]
  86. Nielsen K. B. Sex chromosome aneuploidy in fragile X carriers. Am J Med Genet. 1986 Jan-Feb;23(1-2):537–544. doi: 10.1002/ajmg.1320230146. [DOI] [PubMed] [Google Scholar]
  87. Nistal M., Martínez-García F., Regadera J., Cobo P., Paniagua R. Macro-orchidism: light and electron microscopic study of four cases. Hum Pathol. 1992 Sep;23(9):1011–1018. doi: 10.1016/0046-8177(92)90262-2. [DOI] [PubMed] [Google Scholar]
  88. Nolin S. L., Glicksman A., Houck G. E., Jr, Brown W. T., Dobkin C. S. Mosaicism in fragile X affected males. Am J Med Genet. 1994 Jul 15;51(4):509–512. doi: 10.1002/ajmg.1320510444. [DOI] [PubMed] [Google Scholar]
  89. Oostra B. A., Jacky P. B., Brown W. T., Rousseau F. Guidelines for the diagnosis of fragile X syndrome. National Fragile X Foundation. J Med Genet. 1993 May;30(5):410–413. doi: 10.1136/jmg.30.5.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Opitz J. M. On the gates of hell and a most unusual gene. Am J Med Genet. 1986 Jan-Feb;23(1-2):1–10. doi: 10.1002/ajmg.1320230102. [DOI] [PubMed] [Google Scholar]
  91. Palomaki G. E., Haddow J. E. Is it time for population-based prenatal screening for fragile-X? Lancet. 1993 Feb 6;341(8841):373–374. doi: 10.1016/0140-6736(93)90176-h. [DOI] [PubMed] [Google Scholar]
  92. Palomaki G. E. Population based prenatal screening for the fragile X syndrome. J Med Screen. 1994 Jan;1(1):65–72. doi: 10.1177/096914139400100112. [DOI] [PubMed] [Google Scholar]
  93. Partington M. W., Moore D. Y., Turner G. M. Confirmation of early menopause in fragile X carriers. Am J Med Genet. 1996 Aug 9;64(2):370–372. doi: 10.1002/(SICI)1096-8628(19960809)64:2<370::AID-AJMG27>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  94. Partington M. W. The fragile X syndrome II: preliminary data on growth and development in males. Am J Med Genet. 1984 Jan;17(1):175–194. doi: 10.1002/ajmg.1320170111. [DOI] [PubMed] [Google Scholar]
  95. Pieretti M., Zhang F. P., Fu Y. H., Warren S. T., Oostra B. A., Caskey C. T., Nelson D. L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991 Aug 23;66(4):817–822. doi: 10.1016/0092-8674(91)90125-i. [DOI] [PubMed] [Google Scholar]
  96. Piussan C., Mathieu M., Berquin P., Fryns J. P. Fragile X mutation and FG syndrome-like phenotype. Am J Med Genet. 1996 Aug 9;64(2):395–398. doi: 10.1002/(SICI)1096-8628(19960809)64:2<395::AID-AJMG32>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  97. Prior T. W., Papp A. C., Snyder P. J., Sedra M. S., Guida M., Enrile B. G. Germline mosaicism at the fragile X locus. Am J Med Genet. 1995 Jan 30;55(3):384–386. doi: 10.1002/ajmg.1320550327. [DOI] [PubMed] [Google Scholar]
  98. Purpura D. P. Dendritic spine "dysgenesis" and mental retardation. Science. 1974 Dec 20;186(4169):1126–1128. doi: 10.1126/science.186.4169.1126. [DOI] [PubMed] [Google Scholar]
  99. Quan F., Zonana J., Gunter K., Peterson K. L., Magenis R. E., Popovich B. W. An atypical case of fragile X syndrome caused by a deletion that includes the FMR1 gene. Am J Hum Genet. 1995 May;56(5):1042–1051. [PMC free article] [PubMed] [Google Scholar]
  100. Reiss A. L., Abrams M. T., Greenlaw R., Freund L., Denckla M. B. Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat Med. 1995 Feb;1(2):159–167. doi: 10.1038/nm0295-159. [DOI] [PubMed] [Google Scholar]
  101. Reiss A. L., Freund L. S., Baumgardner T. L., Abrams M. T., Denckla M. B. Contribution of the FMR1 gene mutation to human intellectual dysfunction. Nat Genet. 1995 Nov;11(3):331–334. doi: 10.1038/ng1195-331. [DOI] [PubMed] [Google Scholar]
  102. Reiss A. L., Freund L. Behavioral phenotype of fragile X syndrome: DSM-III-R autistic behavior in male children. 1992 Apr 15-May 1Am J Med Genet. 43(1-2):35–46. doi: 10.1002/ajmg.1320430106. [DOI] [PubMed] [Google Scholar]
  103. Reiss A. L., Freund L., Tseng J. E., Joshi P. K. Neuroanatomy in fragile X females: the posterior fossa. Am J Hum Genet. 1991 Aug;49(2):279–288. [PMC free article] [PubMed] [Google Scholar]
  104. Reyniers E., Vits L., De Boulle K., Van Roy B., Van Velzen D., de Graaff E., Verkerk A. J., Jorens H. Z., Darby J. K., Oostra B. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat Genet. 1993 Jun;4(2):143–146. doi: 10.1038/ng0693-143. [DOI] [PubMed] [Google Scholar]
  105. Richards B. W., Sylvester P. E., Brooker C. Fragile X-linked mental retardation: the Martin-Bell syndrome. J Ment Defic Res. 1981 Dec;25(Pt 4):253–256. doi: 10.1111/j.1365-2788.1981.tb00115.x. [DOI] [PubMed] [Google Scholar]
  106. Rousseau F., Heitz D., Biancalana V., Blumenfeld S., Kretz C., Boué J., Tommerup N., Van Der Hagen C., DeLozier-Blanchet C., Croquette M. F. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med. 1991 Dec 12;325(24):1673–1681. doi: 10.1056/NEJM199112123252401. [DOI] [PubMed] [Google Scholar]
  107. Rousseau F., Heitz D., Oberlé I., Mandel J. L. Selection in blood cells from female carriers of the fragile X syndrome: inverse correlation between age and proportion of active X chromosomes carrying the full mutation. J Med Genet. 1991 Dec;28(12):830–836. doi: 10.1136/jmg.28.12.830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Rousseau F., Heitz D., Tarleton J., MacPherson J., Malmgren H., Dahl N., Barnicoat A., Mathew C., Mornet E., Tejada I. A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. Am J Hum Genet. 1994 Aug;55(2):225–237. [PMC free article] [PubMed] [Google Scholar]
  109. Rousseau F., Robb L. J., Rouillard P., Der Kaloustian V. M. No mental retardation in a man with 40% abnormal methylation at the FMR-1 locus and transmission of sperm cell mutations as premutations. Hum Mol Genet. 1994 Jun;3(6):927–930. doi: 10.1093/hmg/3.6.927. [DOI] [PubMed] [Google Scholar]
  110. Rousseau F., Rouillard P., Morel M. L., Khandjian E. W., Morgan K. Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome. Am J Hum Genet. 1995 Nov;57(5):1006–1018. [PMC free article] [PubMed] [Google Scholar]
  111. Rudelli R. D., Brown W. T., Wisniewski K., Jenkins E. C., Laure-Kamionowska M., Connell F., Wisniewski H. M. Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol. 1985;67(3-4):289–295. doi: 10.1007/BF00687814. [DOI] [PubMed] [Google Scholar]
  112. Schrander-Stumpel C., Gerver W. J., Meyer H., Engelen J., Mulder H., Fryns J. P. Prader-Willi-like phenotype in fragile X syndrome. Clin Genet. 1994 Apr;45(4):175–180. doi: 10.1111/j.1399-0004.1994.tb04018.x. [DOI] [PubMed] [Google Scholar]
  113. Schwartz C. E., Dean J., Howard-Peebles P. N., Bugge M., Mikkelsen M., Tommerup N., Hull C., Hagerman R., Holden J. J., Stevenson R. E. Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet. 1994 Jul 15;51(4):400–402. doi: 10.1002/ajmg.1320510419. [DOI] [PubMed] [Google Scholar]
  114. Shapiro L. R., Simensen R. J., Wilmot P. L., Fisch G. S., Vibert B. K., Fenwick R. G., Tarleton J., Phelan M. C. Asymmetry of methylation with FMR-1 full mutation in two 45,X/46,XX mosaic females associated with normal intellect. Am J Med Genet. 1994 Jul 15;51(4):507–508. doi: 10.1002/ajmg.1320510443. [DOI] [PubMed] [Google Scholar]
  115. Sherman S. L., Jacobs P. A., Morton N. E., Froster-Iskenius U., Howard-Peebles P. N., Nielsen K. B., Partington M. W., Sutherland G. R., Turner G., Watson M. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet. 1985;69(4):289–299. doi: 10.1007/BF00291644. [DOI] [PubMed] [Google Scholar]
  116. Sherman S. L. The high prevalence of fragile X premutation carrier females: is this frequency unique to the French Canadian population? Am J Hum Genet. 1995 Nov;57(5):991–993. [PMC free article] [PubMed] [Google Scholar]
  117. Siomi H., Choi M., Siomi M. C., Nussbaum R. L., Dreyfuss G. Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell. 1994 Apr 8;77(1):33–39. doi: 10.1016/0092-8674(94)90232-1. [DOI] [PubMed] [Google Scholar]
  118. Siomi H., Siomi M. C., Nussbaum R. L., Dreyfuss G. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell. 1993 Jul 30;74(2):291–298. doi: 10.1016/0092-8674(93)90420-u. [DOI] [PubMed] [Google Scholar]
  119. Siomi M. C., Zhang Y., Siomi H., Dreyfuss G. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol Cell Biol. 1996 Jul;16(7):3825–3832. doi: 10.1128/mcb.16.7.3825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Sittler A., Devys D., Weber C., Mandel J. L. Alternative splicing of exon 14 determines nuclear or cytoplasmic localisation of fmr1 protein isoforms. Hum Mol Genet. 1996 Jan;5(1):95–102. doi: 10.1093/hmg/5.1.95. [DOI] [PubMed] [Google Scholar]
  121. Slaney S. F., Wilkie A. O., Hirst M. C., Charlton R., McKinley M., Pointon J., Christodoulou Z., Huson S. M., Davies K. E. DNA testing for fragile X syndrome in schools for learning difficulties. Arch Dis Child. 1995 Jan;72(1):33–37. doi: 10.1136/adc.72.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Smits A. P., Dreesen J. C., Post J. G., Smeets D. F., de Die-Smulders C., Spaans-van der Bijl T., Govaerts L. C., Warren S. T., Oostra B. A., van Oost B. A. The fragile X syndrome: no evidence for any recent mutations. J Med Genet. 1993 Feb;30(2):94–96. doi: 10.1136/jmg.30.2.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Staley L. W., Hull C. E., Mazzocco M. M., Thibodeau S. N., Snow K., Wilson V. L., Taylor A., McGavran L., Weiner D., Riddle J. Molecular-clinical correlations in children and adults with fragile X syndrome. Am J Dis Child. 1993 Jul;147(7):723–726. doi: 10.1001/archpedi.1993.02160310025011. [DOI] [PubMed] [Google Scholar]
  124. Sutcliffe J. S., Nelson D. L., Zhang F., Pieretti M., Caskey C. T., Saxe D., Warren S. T. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet. 1992 Sep;1(6):397–400. doi: 10.1093/hmg/1.6.397. [DOI] [PubMed] [Google Scholar]
  125. Sutherland G. R., Gedeon A., Kornman L., Donnelly A., Byard R. W., Mulley J. C., Kremer E., Lynch M., Pritchard M., Yu S. Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence. N Engl J Med. 1991 Dec 12;325(24):1720–1722. doi: 10.1056/NEJM199112123252407. [DOI] [PubMed] [Google Scholar]
  126. Sutherland G. R. Heritable fragile sites on human chromosomes I. Factors affecting expression in lymphocyte culture. Am J Hum Genet. 1979 Mar;31(2):125–135. [PMC free article] [PubMed] [Google Scholar]
  127. Tamanini F., Meijer N., Verheij C., Willems P. J., Galjaard H., Oostra B. A., Hoogeveen A. T. FMRP is associated to the ribosomes via RNA. Hum Mol Genet. 1996 Jun;5(6):809–813. doi: 10.1093/hmg/5.6.809. [DOI] [PubMed] [Google Scholar]
  128. Tamanini F., Willemsen R., van Unen L., Bontekoe C., Galjaard H., Oostra B. A., Hoogeveen A. T. Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum Mol Genet. 1997 Aug;6(8):1315–1322. doi: 10.1093/hmg/6.8.1315. [DOI] [PubMed] [Google Scholar]
  129. Tarleton J., Richie R., Schwartz C., Rao K., Aylsworth A. S., Lachiewicz A. An extensive de novo deletion removing FMR1 in a patient with mental retardation and the fragile X syndrome phenotype. Hum Mol Genet. 1993 Nov;2(11):1973–1974. doi: 10.1093/hmg/2.11.1973. [DOI] [PubMed] [Google Scholar]
  130. Taylor A. K., Safanda J. F., Fall M. Z., Quince C., Lang K. A., Hull C. E., Carpenter I., Staley L. W., Hagerman R. J. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA. 1994 Feb 16;271(7):507–514. [PubMed] [Google Scholar]
  131. Trottier Y., Imbert G., Poustka A., Fryns J. P., Mandel J. L. Male with typical fragile X phenotype is deleted for part of the FMR1 gene and for about 100 kb of upstream region. Am J Med Genet. 1994 Jul 15;51(4):454–457. doi: 10.1002/ajmg.1320510431. [DOI] [PubMed] [Google Scholar]
  132. Turner A. M., Robinson H., Wake S., Laing S. J., Leigh D., Turner G. Counselling risk figures for fragile X carrier females of varying band sizes for use in predicting the likelihood of retardation in their offspring. Am J Med Genet. 1994 Jul 15;51(4):458–462. doi: 10.1002/ajmg.1320510432. [DOI] [PubMed] [Google Scholar]
  133. Turner G., Eastman C., Casey J., McLeay A., Procopis P., Turner B. X-linked mental retardation associated with macro-orchidism. J Med Genet. 1975 Dec;12(4):367–371. doi: 10.1136/jmg.12.4.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Turner G., Robinson H., Laing S., Purvis-Smith S. Preventive screening for the fragile X syndrome. N Engl J Med. 1986 Sep 4;315(10):607–609. doi: 10.1056/NEJM198609043151002. [DOI] [PubMed] [Google Scholar]
  135. Turner G., Robinson H., Laing S., van den Berk M., Colley A., Goddard A., Sherman S., Partington M. Population screening for fragile X. Lancet. 1992 May 16;339(8803):1210–1213. doi: 10.1016/0140-6736(92)91142-u. [DOI] [PubMed] [Google Scholar]
  136. Turner G., Robinson H., Wake S., Martin N. Dizygous twinning and premature menopause in fragile X syndrome. Lancet. 1994 Nov 26;344(8935):1500–1500. doi: 10.1016/s0140-6736(94)90313-1. [DOI] [PubMed] [Google Scholar]
  137. Turner G., Webb T., Wake S., Robinson H. Prevalence of fragile X syndrome. Am J Med Genet. 1996 Jul 12;64(1):196–197. doi: 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  138. Verheij C., Bakker C. E., de Graaff E., Keulemans J., Willemsen R., Verkerk A. J., Galjaard H., Reuser A. J., Hoogeveen A. T., Oostra B. A. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature. 1993 Jun 24;363(6431):722–724. doi: 10.1038/363722a0. [DOI] [PubMed] [Google Scholar]
  139. Verheij C., de Graaff E., Bakker C. E., Willemsen R., Willems P. J., Meijer N., Galjaard H., Reuser A. J., Oostra B. A., Hoogeveen A. T. Characterization of FMR1 proteins isolated from different tissues. Hum Mol Genet. 1995 May;4(5):895–901. doi: 10.1093/hmg/4.5.895. [DOI] [PubMed] [Google Scholar]
  140. Verkerk A. J., Pieretti M., Sutcliffe J. S., Fu Y. H., Kuhl D. P., Pizzuti A., Reiner O., Richards S., Victoria M. F., Zhang F. P. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991 May 31;65(5):905–914. doi: 10.1016/0092-8674(91)90397-h. [DOI] [PubMed] [Google Scholar]
  141. Verkerk A. J., de Graaff E., De Boulle K., Eichler E. E., Konecki D. S., Reyniers E., Manca A., Poustka A., Willems P. J., Nelson D. L. Alternative splicing in the fragile X gene FMR1. Hum Mol Genet. 1993 Apr;2(4):399–404. doi: 10.1093/hmg/2.4.399. [DOI] [PubMed] [Google Scholar]
  142. Vits L., De Boulle K., Reyniers E., Handig I., Darby J. K., Oostra B., Willems P. J. Apparent regression of the CGG repeat in FMR1 to an allele of normal size. Hum Genet. 1994 Nov;94(5):523–526. doi: 10.1007/BF00211019. [DOI] [PubMed] [Google Scholar]
  143. Voelckel M. A., Pellissier M. C., Piquet C., N'Guyen C., Boccaccio I., Philip N., Mattei J. F. Fragile X syndrome in an extended family with special reference to an affected male with Klinefelter syndrome. Am J Med Genet. 1991 Feb-Mar;38(2-3):374–377. doi: 10.1002/ajmg.1320380243. [DOI] [PubMed] [Google Scholar]
  144. Wang Y. C., Lin M. L., Lin S. J., Li Y. C., Li S. Y. Novel point mutation within intron 10 of FMR-1 gene causing fragile X syndrome. Hum Mutat. 1997;10(5):393–399. doi: 10.1002/(SICI)1098-1004(1997)10:5<393::AID-HUMU10>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  145. Wang Z., Taylor A. K., Bridge J. A. FMR1 fully expanded mutation with minimal methylation in a high functioning fragile X male. J Med Genet. 1996 May;33(5):376–378. doi: 10.1136/jmg.33.5.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Webb T. P., Bundey S., Thake A., Todd J. The frequency of the fragile X chromosome among schoolchildren in Coventry. J Med Genet. 1986 Oct;23(5):396–399. doi: 10.1136/jmg.23.5.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Weiler I. J., Irwin S. A., Klintsova A. Y., Spencer C. M., Brazelton A. D., Miyashiro K., Comery T. A., Patel B., Eberwine J., Greenough W. T. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci U S A. 1997 May 13;94(10):5395–5400. doi: 10.1073/pnas.94.10.5395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Wells R. D. Molecular basis of genetic instability of triplet repeats. J Biol Chem. 1996 Feb 9;271(6):2875–2878. doi: 10.1074/jbc.271.6.2875. [DOI] [PubMed] [Google Scholar]
  149. Willemsen R., Bontekoe C., Tamanini F., Galjaard H., Hoogeveen A., Oostra B. Association of FMRP with ribosomal precursor particles in the nucleolus. Biochem Biophys Res Commun. 1996 Aug 5;225(1):27–33. doi: 10.1006/bbrc.1996.1126. [DOI] [PubMed] [Google Scholar]
  150. Willemsen R., Los F., Mohkamsing S., van den Ouweland A., Deelen W., Galjaard H., Oostra B. Rapid antibody test for prenatal diagnosis of fragile X syndrome on amniotic fluid cells: a new appraisal. J Med Genet. 1997 Mar;34(3):250–251. doi: 10.1136/jmg.34.3.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Willemsen R., Mohkamsing S., de Vries B., Devys D., van den Ouweland A., Mandel J. L., Galjaard H., Oostra B. Rapid antibody test for fragile X syndrome. Lancet. 1995 May 6;345(8958):1147–1148. doi: 10.1016/s0140-6736(95)90979-6. [DOI] [PubMed] [Google Scholar]
  152. Willemsen R., Oosterwijk J. C., Los F. J., Galjaard H., Oostra B. A. Prenatal diagnosis of fragile X syndrome. Lancet. 1996 Oct 5;348(9032):967–968. doi: 10.1016/s0140-6736(05)65388-3. [DOI] [PubMed] [Google Scholar]
  153. Wisniewski K. E., Segan S. M., Miezejeski C. M., Sersen E. A., Rudelli R. D. The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet. 1991 Feb-Mar;38(2-3):476–480. doi: 10.1002/ajmg.1320380267. [DOI] [PubMed] [Google Scholar]
  154. Wolff D. J., Gustashaw K. M., Zurcher V., Ko L., White W., Weiss L., Van Dyke D. L., Schwartz S., Willard H. F. Deletions in Xq26.3-q27.3 including FMR1 result in a severe phenotype in a male and variable phenotypes in females depending upon the X inactivation pattern. Hum Genet. 1997 Aug;100(2):256–261. doi: 10.1007/s004390050501. [DOI] [PubMed] [Google Scholar]
  155. Wöhrle D., Hennig I., Vogel W., Steinbach P. Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion. Nat Genet. 1993 Jun;4(2):140–142. doi: 10.1038/ng0693-140. [DOI] [PubMed] [Google Scholar]
  156. Wöhrle D., Kotzot D., Hirst M. C., Manca A., Korn B., Schmidt A., Barbi G., Rott H. D., Poustka A., Davies K. E. A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. Am J Hum Genet. 1992 Aug;51(2):299–306. [PMC free article] [PubMed] [Google Scholar]
  157. Yu S., Pritchard M., Kremer E., Lynch M., Nancarrow J., Baker E., Holman K., Mulley J. C., Warren S. T., Schlessinger D. Fragile X genotype characterized by an unstable region of DNA. Science. 1991 May 24;252(5009):1179–1181. doi: 10.1126/science.252.5009.1179. [DOI] [PubMed] [Google Scholar]
  158. Zhong N., Ju W., Pietrofesa J., Wang D., Dobkin C., Brown W. T. Fragile X "gray zone" alleles: AGG patterns, expansion risks, and associated haplotypes. Am J Med Genet. 1996 Aug 9;64(2):261–265. doi: 10.1002/(SICI)1096-8628(19960809)64:2<261::AID-AJMG5>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  159. Zhong N., Yang W., Dobkin C., Brown W. T. Fragile X gene instability: anchoring AGGs and linked microsatellites. Am J Hum Genet. 1995 Aug;57(2):351–361. [PMC free article] [PubMed] [Google Scholar]
  160. de Graaff E., de Vries B. B., Willemsen R., van Hemel J. O., Mohkamsing S., Oostra B. A., van den Ouweland A. M. The fragile X phenotype in a mosaic male with a deletion showing expression of the FMR1 protein in 28% of the cells. Am J Med Genet. 1996 Aug 9;64(2):302–308. doi: 10.1002/(SICI)1096-8628(19960809)64:2<302::AID-AJMG14>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  161. de Vries B. B., Fryns J. P., Butler M. G., Canziani F., Wesby-van Swaay E., van Hemel J. O., Oostra B. A., Halley D. J., Niermeijer M. F. Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype. J Med Genet. 1993 Sep;30(9):761–766. doi: 10.1136/jmg.30.9.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. de Vries B. B., Jansen C. C., Duits A. A., Verheij C., Willemsen R., van Hemel J. O., van den Ouweland A. M., Niermeijer M. F., Oostra B. A., Halley D. J. Variable FMR1 gene methylation of large expansions leads to variable phenotype in three males from one fragile X family. J Med Genet. 1996 Dec;33(12):1007–1010. doi: 10.1136/jmg.33.12.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. de Vries B. B., Robinson H., Stolte-Dijkstra I., Tjon Pian Gi C. V., Dijkstra P. F., van Doorn J., Halley D. J., Oostra B. A., Turner G., Niermeijer M. F. General overgrowth in the fragile X syndrome: variability in the phenotypic expression of the FMR1 gene mutation. J Med Genet. 1995 Oct;32(10):764–769. doi: 10.1136/jmg.32.10.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. de Vries B. B., van den Ouweland A. M., Mohkamsing S., Duivenvoorden H. J., Mol E., Gelsema K., van Rijn M., Halley D. J., Sandkuijl L. A., Oostra B. A. Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet. 1997 Sep;61(3):660–667. doi: 10.1086/515496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. van den Ouweland A. M., Deelen W. H., Kunst C. B., Uzielli M. L., Nelson D. L., Warren S. T., Oostra B. A., Halley D. J. Loss of mutation at the FMR1 locus through multiple exchanges between maternal X chromosomes. Hum Mol Genet. 1994 Oct;3(10):1823–1827. doi: 10.1093/hmg/3.10.1823. [DOI] [PubMed] [Google Scholar]
  166. van den Ouweland A. M., de Vries B. B., Bakker P. L., Deelen W. H., de Graaff E., van Hemel J. O., Oostra B. A., Niermeijer M. F., Halley D. J. DNA diagnosis of the fragile X syndrome in a series of 236 mentally retarded subjects and evidence for a reversal of mutation in the FMR-1 gene. Am J Med Genet. 1994 Jul 15;51(4):482–485. doi: 10.1002/ajmg.1320510437. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES